Dorman SE - Search Results

1

A novel mutation in IFN-gamma receptor 2 with dominant negative activity: biological consequences of homozygous and heterozygous states.

Rosenzweig SD, Dorman SE, Uzel G, Shaw S, Scurlock A, Brown MR, Buckley RH, Holland SM. Rosenzweig SD, et al. Among authors: dorman se. J Immunol. 2004 Sep 15;173(6):4000-8. doi: 10.4049/jimmunol.173.6.4000. J Immunol. 2004. PMID: 15356149

2

Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies.

Dorman SE, Picard C, Lammas D, Heyne K, van Dissel JT, Baretto R, Rosenzweig SD, Newport M, Levin M, Roesler J, Kumararatne D, Casanova JL, Holland SM. Dorman SE, et al. Lancet. 2004 Dec 11-17;364(9451):2113-21. doi: 10.1016/S0140-6736(04)17552-1. Lancet. 2004. PMID: 15589309

3

Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection.

Dorman SE, Holland SM. Dorman SE, et al. J Clin Invest. 1998 Jun 1;101(11):2364-9. doi: 10.1172/JCI2901. J Clin Invest. 1998. PMID: 9616207 Free PMC article.

4

Abnormal regulation of interferon-gamma, interleukin-12, and tumor necrosis factor-alpha in human interferon-gamma receptor 1 deficiency.

Holland SM, Dorman SE, Kwon A, Pitha-Rowe IF, Frucht DM, Gerstberger SM, Noel GJ, Vesterhus P, Brown MR, Fleisher TA. Holland SM, et al. Among authors: dorman se. J Infect Dis. 1998 Oct;178(4):1095-104. doi: 10.1086/515670. J Infect Dis. 1998. PMID: 9806040

5

Viral infections in interferon-gamma receptor deficiency.

Dorman SE, Uzel G, Roesler J, Bradley JS, Bastian J, Billman G, King S, Filie A, Schermerhorn J, Holland SM. Dorman SE, et al. J Pediatr. 1999 Nov;135(5):640-3. doi: 10.1016/s0022-3476(99)70064-8. J Pediatr. 1999. PMID: 10547254 Free PMC article.

6

Interferon-gamma and interleukin-12 pathway defects and human disease.

Dorman SE, Holland SM. Dorman SE, et al. Cytokine Growth Factor Rev. 2000 Dec;11(4):321-33. doi: 10.1016/s1359-6101(00)00010-1. Cytokine Growth Factor Rev. 2000. PMID: 10959079 Review.

7

561del4 defines a novel small deletion hotspot in the interferon-gamma receptor 1 chain.

Rosenzweig S, Dorman SE, Roesler J, Palacios J, Zelazko M, Holland SM. Rosenzweig S, et al. Among authors: dorman se. Clin Immunol. 2002 Jan;102(1):25-7. doi: 10.1006/clim.2001.5135. Clin Immunol. 2002. PMID: 11781064

8

Nocardia infection in chronic granulomatous disease.

Dorman SE, Guide SV, Conville PS, DeCarlo ES, Malech HL, Gallin JI, Witebsky FG, Holland SM. Dorman SE, et al. Clin Infect Dis. 2002 Aug 15;35(4):390-4. doi: 10.1086/341416. Epub 2002 Jul 23. Clin Infect Dis. 2002. PMID: 12145721

9

Detection of intracellular phosphorylated STAT-1 by flow cytometry.

Fleisher TA, Dorman SE, Anderson JA, Vail M, Brown MR, Holland SM. Fleisher TA, et al. Among authors: dorman se. Clin Immunol. 1999 Mar;90(3):425-30. doi: 10.1006/clim.1998.4654. Clin Immunol. 1999. PMID: 10075873

10

Neutrophil-specific granule deficiency results from a novel mutation with loss of function of the transcription factor CCAAT/enhancer binding protein epsilon.

Lekstrom-Himes JA, Dorman SE, Kopar P, Holland SM, Gallin JI. Lekstrom-Himes JA, et al. Among authors: dorman se. J Exp Med. 1999 Jun 7;189(11):1847-52. doi: 10.1084/jem.189.11.1847. J Exp Med. 1999. PMID: 10359588 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters